Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-05-14
STMLStemline Therapeutics IncHoberman KennethCOOS - Sale$14.27-25,817729,879-3%-$368,409
2019-05-16
NKTRNektar TherapeuticsThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$31.37-1,928164,463-1%-$60,481
2019-05-16
NKTRNektar TherapeuticsRobin Howard WPres, CEOS - Sale$31.37-13,383295,736-4%-$419,825
2019-05-16
NKTRNektar TherapeuticsNicholson JohnSVP, COOS - Sale$31.37-4,077166,578-2%-$127,895
2019-05-16
NKTRNektar TherapeuticsLabrucherie Gil MSVP, CFOS - Sale$31.37-3,767127,935-3%-$118,171
2019-05-16
NKTRNektar TherapeuticsHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$31.37-2,44994,694-3%-$76,825
2019-05-16
NKTRNektar TherapeuticsDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$31.37-3,46195,913-3%-$108,572
D
2019-05-15
GWPHGw Pharmaceuticals PlcTovey Christopher J.COOS - Sale+OE$15.01-1,2002,503-32%-$18,012
M
2019-05-15
FTSVForty Seven, Inc.Majeti RavindraDirS - Sale$16.02-4,3111,421,4000%-$69,044
2019-05-16
SPPISpectrum Pharmaceuticals IncTurgeon Joseph W.CEO, PresS - Sale$8.53-22,702449,217-5%-$193,755
M
2019-02-15
AGLEAeglea Biotherapeutics, Inc.Quinn Anthony G.Pres, CEOP - Purchase$6.75+18,713295,146+7%+$126,399
2019-05-15
VRTXVertex Pharmaceuticals Inc / MaSachdev AmitEVP, CROS - Sale$165.41-6153,2620%-$10,090
M
2019-05-13
ENDVEndonovo Therapeutics, Inc.Collier Alan BrianCEOP - Purchase$0.01+81,50021,834,3970%+$1,037
2019-05-15
VRTXVertex Pharmaceuticals Inc / MaSilva Paul MSVP, ControllerS - Sale$165.41-16117,928-1%-$26,631
2019-05-15
VRTXVertex Pharmaceuticals Inc / MaParini MichaelEVP, CL, AOS - Sale$165.41-8335,0030%-$13,729
2019-05-15
VRTXVertex Pharmaceuticals Inc / MaKewalramani ReshmaEVP, CMOS - Sale$165.41-24113,736-2%-$39,864
2019-05-15
VRTXVertex Pharmaceuticals Inc / MaArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale$165.41-13333,3800%-$22,000
2019-05-15
VRTXVertex Pharmaceuticals Inc / MaAltshuler DavidEVP, Global Research, CSOS - Sale$165.41-9131,5530%-$15,052
D
2019-05-15
ALNYAlnylam Pharmaceuticals, Inc.Maraganore JohnCEOS - Sale+OE$70.00-49,457193,092-20%-$3,461,990
2019-05-15
COLLCollegium Pharmaceutical, IncHeffernan Michael ThomasDirS - Sale$12.84-25,000182,069-12%-$321,042
2019-05-15
QUREUniqure N.V.Kapusta Matthew CCEO, CFO, MDS - Sale$58.38-8,000415,230-2%-$467,017
2019-05-14
CNABUnited Cannabis CorpVerzura Tony10%S - Sale$0.25-200,00011,735,885-2%-$50,000
2019-05-15
BSTCBiospecifics Technologies CorpGitman PaulDirS - Sale$65.83-5,00015,000-25%-$329,150
D
2019-05-15
RETAReata Pharmaceuticals IncWilson Jason DouglasCFOS - Sale+OE$89.91-4,0000-100%-$359,631
D
2019-05-15
CRMDCormedix Inc.Dillione JanetDirP - Purchase$6.74+11,14447,326+31%+$75,111
2019-05-16
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$2.02+100,000215,841,6330%+$202,139
M
2019-05-15
RTRXRetrophin, Inc.McFarlane Neil F.COOS - Sale$18.25-1,96826,988-7%-$35,906
M
2019-05-15
RTRXRetrophin, Inc.Clague LauraCFOS - Sale$18.25-2,50013,500-16%-$45,613
M
2019-05-14
RTRXRetrophin, Inc.Rote William E.SVP, R, DS - Sale$17.77-1,62518,185-8%-$28,876
M
2019-05-14
RTRXRetrophin, Inc.Reed Elizabeth ESVP, GC, Corporate SecretaryS - Sale$17.73-1,05019,508-5%-$18,617
M
2019-05-14
RTRXRetrophin, Inc.Aselage SteveDirS - Sale$17.80-3,676255,966-1%-$65,451
2019-05-15
CTLTCatalent, Inc.Morel Donald E JrDirP - Purchase$44.44+10,00046,958+27%+$444,400
D
2019-05-14
URGNUrogen Pharma Ltd.Mullennix StephenCOOS - Sale+OE$37.98-6085,381-10%-$23,092
M
2019-05-14
NERVMinerva Neurosciences, Inc.Index Venture Associates III Ltd10%S - Sale$6.66-134,8284,474,361-3%-$898,161
DM
2019-05-14
SVRASavara IncHawkins Richard JDirS - Sale+OE$11.10-25,0000-100%-$277,622
D
2019-05-16
RGLSRegulus Therapeutics Inc.Hagan Joseph PPres, CEOS - Sale+OE$1.22-39,352268,167-13%-$47,966
D
2019-05-15
RGLSRegulus Therapeutics Inc.Chevallard Daniel R.CFOS - Sale+OE$1.41-10,00080,539-11%-$14,089
D
2019-05-15
RGLSRegulus Therapeutics Inc.Aker Christopher RaySVP, GCS - Sale+OE$1.41-6,95059,309-10%-$9,796
2019-05-15
AMRXAmneal Pharmaceuticals, Inc.Bhadauria PradeepSVP, Chief Scientific OfficerP - Purchase$8.48+7,0007,500>999%+$59,360
D
2019-05-14
ZTSZoetis Inc.Lewis Clinton A. Jr.EVPS - Sale+OE$101.90-6,12345,803-12%-$623,934
A
2019-05-03
LLYLilly Eli & CoShaw ChristiSVP, Pres, Lilly Bio-MedsS - Sale$117.08-7,077500-93%-$828,575
D
2019-05-14
CERCCerecor Inc.Pedder SimonExec COB of the BdP - Purchase$5.06+6,0006,000New+$30,336
2019-05-14
LGNDLigand Pharmaceuticals IncAryeh JasonDirP - Purchase$112.51+250115,9870%+$28,128
2019-05-16
CLSNCelsion CorpTardugno Michael HCOB, Pres, CEOP - Purchase$2.16+5,00032,700+18%+$10,810
2019-05-16
CLSNCelsion CorpMartinez Alberto R JrDirP - Purchase$2.15+4,00024,000+20%+$8,600
2019-05-15
HRTXHeron Therapeutics, Inc. /de/Christian WaageDirP - Purchase$18.04+1,4001,400New+$25,262
D
2019-05-15
VTVTVtv Therapeutics Inc.Perelman Ronald O10%P - Purchase$1.84+1,358,69817,852,351+8%+$2,500,004
2019-05-15
REGNRegeneron Pharmaceuticals IncGoldstein Joseph LDirS - Sale$305.93-1,00011,323-8%-$305,930
DM
2019-05-13
FGENFibrogen IncNeff Thomas BCEOS - Sale+OE$36.34-39,6362,642,114-1%-$1,440,554
D
2019-05-13
MRTXMirati Therapeutics, Inc.Grey Michael GDirS - Sale+OE$65.30-5,7601,340-81%-$376,138
M
2019-05-13
VRCAVerrica Pharmaceuticals Inc.Davidson Matt10%S - Sale$9.11-6,9732,719,1190%-$63,554
2019-05-14
ITCIIntra-Cellular Therapies, Inc.Alafi Christopher DDirP - Purchase$12.56+100,0005,307,129+2%+$1,256,350
D
2019-05-13
NXTCNextcure, Inc.Sofinnova Venture Partners Ix, L.P.10%P - Purchase$15.00+400,0002,521,856+19%+$6,000,000
2019-05-14
SAVACassava Sciences IncSchoen EricCFOP - Purchase$1.06+10,00010,000New+$10,600
2019-05-13
ELANElanco Animal Health IncBilbrey John PDirP - Purchase$32.39+7,75010,533+278%+$251,023
M
2019-05-13
ANIPAni Pharmaceuticals IncPrzybyl ArthurPres, CEOS - Sale$70.07-30,000202,589-13%-$2,102,177
2019-05-13
TXMDTherapeuticsmd, Inc.Collins Cooper C.DirP - Purchase$3.33+30,00066,000+83%+$99,870
2019-05-15
ANIPAni Pharmaceuticals IncHaughey ThomasDirP - Purchase$69.30+2,5006,291+66%+$173,240
2019-05-14
ANIPAni Pharmaceuticals IncMarken James G.SVP Ops, Prod DevS - Sale$70.31-4,91770,137-7%-$345,714
2019-05-15
LCILannett Co IncFarber JeffreyDirP - Purchase$5.80+5,0002,101,0540%+$29,000
D
2019-05-14
RLMDRelmada Therapeutics, Inc.Kelly Paul EdwardDirP - Purchase$1.50+100,000488,483+26%+$150,000
D
2019-05-13
REPHRecro Pharma, Inc.Henwood GeraldinePres, CEOS - Sale+OE$8.89-144,806248,141-37%-$1,287,296
2019-05-13
FLXNFlexion Therapeutics IncArkowitz DavidCFOP - Purchase$11.99+4,00086,924+5%+$47,960
D
2019-05-14
REGNRegeneron Pharmaceuticals IncStahl NeilEVP Research, DevelopmentS - Sale+OE$305.74-9,85344,681-18%-$3,012,483
2019-05-13
BGNEBeigene, Ltd.Glazer Donald W.DirS - Sale$125.11-15,0273,949,6780%-$1,880,028
D
2019-05-13
MISTMilestone Pharmaceuticals Inc.Fonds De Solidarite Des Travailleurs Du Quebec10%P - Purchase$15.00+433,3332,720,310+19%+$6,499,995
2019-05-13
DRRXDurect CorpSaxe Jon SDirP - Purchase$0.71+9,600122,810+8%+$6,773
2019-05-14
CRBPCorbus Pharmaceuticals Holdings, Inc.Millian Craig StuartChief Commercial OfficerP - Purchase$7.23+1,0006,000+20%+$7,227
2019-05-13
AKRXAkorn IncRappuhn Terry AllisonDirP - Purchase$4.03+10,00068,198+17%+$40,300
2019-05-13
AXSMAxsome Therapeutics, Inc.Coleman MarkDirP - Purchase$21.44+4,650657,748+1%+$99,696
2019-05-14
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$2.00+1,000,000215,741,6330%+$1,995,024
2019-05-14
APVOAptevo Therapeutics Inc.White Marvin LPres, CEOP - Purchase$0.78+10,000213,603+5%+$7,800
D
2019-05-10
GWPHGw Pharmaceuticals PlcGangolli Julian SPres, North AmericaS - Sale+OE$14.84-671,928106,548-86%-$9,973,283
2019-05-14
LGNDLigand Pharmaceuticals IncHiggins John LCEOP - Purchase$113.50+2,500143,899+2%+$283,750
D
2019-05-14
LGNDLigand Pharmaceuticals IncKozarich John WDirS - Sale+OE$112.92-2,50025,542-9%-$282,300
M
2019-05-10
CERCCerecor Inc.Armistice Capital, LLCDir, 10%P - Purchase$4.97+20,00036,938,5700%+$99,312
D
2019-05-10
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$82.52-10,000507,861-2%-$825,193
2019-05-13
DRRXDurect CorpSaxe Jon SDirP - Purchase$0.70+40,40085,400+90%+$28,095
2019-05-14
ICPTIntercept Pharmaceuticals, Inc.Benatti LucaDirP - Purchase$83.50+1,2007,556+19%+$100,200
2019-05-10
XOMAXoma CorpVan Ness W DenmanDirS - Sale$14.71-1309,945-1%-$1,912
2019-05-13
TXMDTherapeuticsmd, Inc.Thompson Tommy GDirP - Purchase$3.34+2,400690,4560%+$8,016
2019-05-14
SPPISpectrum Pharmaceuticals IncRiga Thomas JEVP, COO, CCOS - Sale$8.82-2,388266,133-1%-$21,069
2019-05-14
SPPISpectrum Pharmaceuticals IncMcGahan Keith MSVP, GCS - Sale$8.82-458141,2900%-$4,041
D
2019-05-10
BDSIBiodelivery Sciences International IncBroadfin Healthcare Master Fund LtdDirS - Sale+OE$5.00-1,800,0004,281,943-30%-$9,000,000
D
2019-05-13
MISTMilestone Pharmaceuticals Inc.Novo Holdings A/s10%P - Purchase$15.00+333,3332,674,470+14%+$4,999,995
D
2019-05-13
ZTSZoetis Inc.Peck Kristin CEVPS - Sale+OE$100.92-11,50041,377-22%-$1,160,580
2019-05-10
IRWDIronwood Pharmaceuticals IncMcCourt Thomas APresS - Sale$10.53-4,055107,239-4%-$42,699
2019-05-10
IRWDIronwood Pharmaceuticals IncGilbert Halley EChief Admin Officer, SVPS - Sale$10.53-4,055238,240-2%-$42,699
2019-05-10
IRWDIronwood Pharmaceuticals IncCurrie Mark GDirS - Sale$10.53-4,055528,903-1%-$42,699
2019-05-13
YMABY-Mabs Therapeutics, Inc.Gad ThomasPres, COBS - Sale$20.61-6,0001,964,5570%-$123,647
2019-05-10
IRWDIronwood Pharmaceuticals IncConsylman GinaSVP, CFO, TreasurerS - Sale$10.53-4,055175,860-2%-$42,699
2019-05-14
CRBPCorbus Pharmaceuticals Holdings, Inc.Moran Sean F.CFOP - Purchase$7.12+100349,6100%+$712
D
2019-05-10
PKTXProtokinetix, Inc.Guzzetta Michael RichardCFOP - Purchase$0.12+2,50069,987+4%+$288
2019-05-13
CRBPCorbus Pharmaceuticals Holdings, Inc.Cohen YuvalCEOP - Purchase$6.99+99564,185+2%+$6,955
D
2019-05-13
CRTXCortexyme, Inc.Pfizer Inc10%P - Purchase$17.00+50,0003,249,973+2%+$850,000
2019-05-13
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$1.99+200,000214,741,6330%+$397,687
2019-05-13
OPKOpko Health, Inc.Pfenniger Richard C JrDirP - Purchase$2.05+50,000220,000+29%+$102,492
D
2019-05-13
NXTCNextcure, Inc.Shannon Timothy MDirP - Purchase$15.00+50,0002,254,442+2%+$750,000
D
2019-05-13
NXTCNextcure, Inc.Khuong Chau QuangDirP - Purchase$15.00+350,0002,711,013+15%+$5,250,000
D
2019-05-13
NXTCNextcure, Inc.Xu StellaDirP - Purchase$15.00+125,0001,103,570+13%+$1,875,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top